Triclosan Loaded Ureteral Stents Decrease Proteus Mirabilis 296 Infection in a Rabbit Urinary Tract Infection Model

Journal of Urology

Volumn 175, Issue 6, 2006, Pages 2331-2335

  Cadieux, Peter A ^a,b   Chew, Ben H ^a,b   Knudsen, Bodo E ^a,b   DeJong, Kathy ^a   Rowe, Elaine ^a   Reid, Gregor ^a,b   Denstedt, John D ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b Can R and D Ctr for Probiotics   (Canada)

Author keywords

rabbits; stents; triclosan; ureter; urinary tract infections

Indexed keywords

ANTIINFECTIVE AGENT; TRICLOSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYSTITIS; DEVICE INFECTION; DRUG ELUTING STENT; ERADICATION THERAPY; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; RABBIT; URETER STENT; URINALYSIS; URINARY TRACT INFECTION; URINE CULTURE;

ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; MALE; PROTEUS INFECTIONS; PROTEUS MIRABILIS; RABBITS; STENTS; TRICLOSAN; URETER; URINARY TRACT INFECTIONS;

EID: 33646369134     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(06)00252-7     Document Type: Article

References (20)

1. Tieszer C., Reid G., and Denstedt J. Conditioning film deposition on ureteral stents after implantation. J Urol 160 (1998) 876
2. Kunin C.M. Urinary Tract Infections. Detection, Prevention and Management (2004), Williams and Wilkins, Baltimore
3. Morris N.S., Stickler D.J., and Winters C. Which indwelling urethral catheters resist encrustation by Proteus mirabilis biofilms?. Br J Urol 80 (1997) 58
4. Barbolt T.A. Chemistry and safety of triclosan, and its use as an antimicrobial coating on Coated VICRYL* Plus Antibacterial Suture (coated polyglactin 910 suture with triclosan). Surg Infect (Larchmt) 3 suppl. (2002) S45
5. Rothenburger S., Spangler D., Bhende S., and Burkley D. In vitro antimicrobial evaluation of Coated VICRYL* Plus Antibacterial Suture (coated polyglactin 910 with triclosan) using zone of inhibition assays. Surg Infect (Larchmt) 3 suppl. (2002) S79
6. Storch M., Perry L.C., Davidson J.M., and Ward J.J. A 28-day study of the effect of Coated VICRYL* Plus Antibacterial Suture (coated polyglactin 910 suture with triclosan) on wound healing in guinea pig linear incisional skin wounds. Surg Infect (Larchmt) 3 suppl. (2002) S89
7. Skaare A.B., Kjaerheim V., Barkvoll P., and Rolla G. Does the nature of the solvent affect the anti-inflammatory capacity of triclosan? An experimental study. J Clin Periodontol 24 (1997) 124
8. Stickler D.J., Jones G.L., and Russell A.D. Control of encrustation and blockage of Foley catheters. Lancet 361 (2003) 1435
9. Fung L.C., Mittelman M.W., Thorner P.S., and Khoury A.E. A novel rabbit model for the evaluation of biomaterial associated urinary tract infection. Can J Urol 10 (2003) 2007
10. Bhargava H.N., and Leonard P.A. Triclosan. applications and safety. Am J Infect Control 24 (1996) 209
11. Matsuyama T., Takagi Y., Nakagawa Y., Itoh H., Wakita J., and Matsushita M. Dynamic aspects of the structured cell population in a swarming colony of Proteus mirabilis. J Bacteriol 182 (2000) 385
12. Watterson J.D., Cadieux P.A., Beiko D.T., Cook A.J., Burton J.P., Harbottle R.R., et al. Oxalate-degrading enzymes from Oxalobacter formigenes. a novel device coating to reduce urinary tract biomaterial-related encrustation. J Endourol 17 (2003) 269
13. McMurry L.M., Oethinger M., and Levy S.B. Triclosan targets lipid synthesis. Nature 394 (1998) 531
14. Mittelman M., Bucay-Cuto W., Li J., Miller K., Schuermann J., and Denstedt J.D. In vitro antimicrobial release profile of a new triclosan-eluting ureteral stent. J Urol 171 (2004) 443
15. Moss T., Howes D., and Williams F.M. Percutaneous penetration and dermal metabolism of triclosan (2,4, 4′-trichloro-2′-hydroxydiphenyl ether). Food Chem Toxicol 38 (2000) 361
16. Braoudaki M., and Hilton A.C. Low level of cross-resistance between triclosan and antibiotics in Escherichia coli K-12 and E. coli O55 compared to E. coli O157. FEMS Microbiol Lett 235 (2004) 305
17. Chuanchuen R., Beinlich K., Hoang T.T., Becher A., Karkhoff-Schweizer R.R., and Schweizer H.P. Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps. exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ. Antimicrob Agents Chemother 45 (2001) 428
18. Heath R.J., and Rock C.O. A triclosan-resistant bacterial enzyme. Nature 406 (2000) 145
19. McBain A.J., Ledder R.G., Sreenivasan P., and Gilbert P. Selection for high-level resistance by chronic triclosan exposure is not universal. J Antimicrob Chemother 53 (2004) 772
20. Russell A.D. Biocide use and antibiotic resistance. the relevance of laboratory findings to clinical and environmental situations. Lancet Infect Dis 3 (2003) 794